|
1
|
Assmann V, Marshall JF, Fieber C, Hofmann
M and Hart IR: The human hyaluronan receptor RHAMM is expressed as
an intracellular protein in breast cancer cells. J Cell Sci.
111:1685–1694. 1998.PubMed/NCBI
|
|
2
|
Li H, Guo L, Li J, Liu N and Liu J:
Alternative splicing of RHAMM gene in chinese gastric cancers and
its in vitro regulation. Zhonghua Yi Xue Yi Chuan Xue Za Zhi.
17:343–347. 2000.(In Chinese). PubMed/NCBI
|
|
3
|
Lin SL, Chang D, Chiang A and Ying SY:
Androgen receptor regulates CD168 expression and signaling in
prostate cancer. Carcinogenesis. 29:282–290. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zlobec I, Steele R, Terracciano L, Jass JR
and Lugli A: Selecting immunohistochemical cut-off scores for novel
biomarkers of progression and survival in colorectal cancer. J Clin
Pathol. 60:1112–1116. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yang B, Zhang L and Turley EA:
Identification of two hyaluronan-binding domains in the hyaluronan
receptor RHAMM. J Biol Chem. 268:8617–8623. 1993.PubMed/NCBI
|
|
6
|
Maxwell CA, Benitez J, Gomez-Baldó L,
Osorio A, Bonifaci N, Fernández-Ramires R, Costes SV, Guinó E, Chen
H, Evans GJ, et al: Interplay between BRCA1 and RHAMM regulates
epithelial apicobasal polarization and may influence risk of breast
cancer. PLoS Biol. 9:e10011992011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gouëffic Y, Guilluy C, Guérin P, Patra P,
Pacaud P and Loirand G: Hyaluronan induces vascular smooth muscle
cell migration through RHAMM-mediated PI3K-dependent Rac
activation. Cardiovasc Res. 72:339–348. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hamilton SR, Fard SF, Paiwand FF, Tolg C,
Veiseh M, Wang C, McCarthy JB, Bissell MJ, Koropatnick J and Turley
EA: The hyaluronan receptors CD44 and Rhamm (CD168) form complexes
with ERK1,2 that sustain high basal motility in breast cancer
cells. J Biol Chem. 282:16667–16680. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hall CL, Wang C, Lange LA and Turley EA:
Hyaluronan and the hyaluronan receptor RHAMM promote focal adhesion
turnover and transient tyrosine kinase activity. J Cell Biol.
126:575–588. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Auvinen P, Tammi R, Kosma VM, Sironen R,
Soini Y, Mannermaa A, Tumelius R, Uljas E and Tammi M: Increased
hyaluronan content and stromal cell CD44 associate with HER2
positivity and poor prognosis in human breast cancer. Int J Cancer.
132:531–539. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ishigami S, Ueno S, Nishizono Y, Matsumoto
M, Kurahara H, Arigami T, Uchikado Y, Setoyama T, Arima H, Yoshiaki
K, et al: Prognostic impact of CD168 expression in gastric cancer.
BMC Cancer. 11:1062011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lee SA, Kwon HC, Park MA, Jung CK, Kim SH,
Park KJ, Choi HJ, Lee HS, Roh MS and Kim JS: Impact of the new AJCC
staging system and adjuvant treatment in rectal cancer. Cancer Res
Treat. 36:121–127. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hilska M, Roberts PJ, Collan YU, Laine VJ,
Kossi J, Hirsimaki P, Rahkonen O and Laato M: Prognostic
significance of matrix metalloproteinases-1, −2, −7 and −13 and
tissue inhibitors of metalloproteinases-1, −2, −3 and −4 in
colorectal cancer. Int J Cancer. 121:714–723. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hsu SM, Raine L and Fanger H: Use of
avidin-biotin-peroxidase complex (ABC) in immunoperoxidase
techniques: a comparison between ABC and unlabeled antibody (PAP)
procedures. J Histochem Cytochem. 29:577–580. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lin SL, Chang D, Chiang A and Ying SY:
Androgen receptor regulates CD168 expression and signaling in
prostate cancer. Carcinogenesis. 29:282–290. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Maxwell CA, Rasmussen E, Zhan F, Keats JJ,
Adamia S, Strachan E, Crainie M, Walker R, Belch AR, Pilarski LM,
et al: RHAMM expression and isoform balance predict aggressive
disease and poor survival in multiple myeloma. Blood.
104:1151–1158. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Abetamann V, Kern HF and Elsässer HP:
Differential expression of the hyaluronan receptors CD44 and RHAMM
in human pancreatic cancer cells. Clin Cancer Res. 2:1607–1618.
1996.PubMed/NCBI
|
|
18
|
Wang C, Thor AD, Moore DH II, Zhao Y,
Kerschmann R, Stern R, Watson PH and Turley EA: The overexpression
of RHAMM, a hyaluronan-binding protein that regulates ras
signaling, correlates with overexpression of mitogen-activated
protein kinase and is a significant parameter in breast cancer
progression. Clin Cancer Res. 4:567–576. 1998.PubMed/NCBI
|
|
19
|
Zlobec I, Baker K, Terracciano L, Peter S,
Degen L, Beglinger C and Lugli A: Two-marker protein profile
predicts poor prognosis in patients with early rectal cancer. Br J
Cancer. 99:1712–1717. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Turner RR, Li C and Compton CC: Newer
pathologic assessment techniques for colorectal carcinoma. Clin
Cancer Res. 13(Suppl): S6871–S6876. 2007. View Article : Google Scholar
|
|
21
|
Samuel SK, Hurta RA, Spearman MA, Wright
JA, Turley EA and Greenberg AH: TGF-beta 1 stimulation of cell
locomotion utilizes the hyaluronan receptor RHAMM and hyaluronan. J
Cell Biol. 123:749–758. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Akiyama Y, Jung S, Salhia B, Lee S,
Hubbard S, Taylor M, Mainprize T, Akaishi K, van Furth W and Rutka
JT: Hyaluronate receptors mediating glioma cell migration and
proliferation. J Neurooncol. 53:115–127. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shigeishi H, Fujimoto S, Hiraoka M, Ono S,
Taki M, Ohta K, Higashikawa K and Kamata N: Overexpression of the
receptor for hyaluronan-mediated motility, correlates with
expression of microtubule-associated protein in human oral squamous
cell carcinomas. Int J Oncol. 34:1565–1571. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yamada Y, Itano N, Narimatsu H, Kudo T,
Hirohashi S, Ochiai A, Niimi A, Ueda M and Kimata K: Receptor for
hyaluronan-mediated motility and CD44 expressions in colon cancer
assessed by quantitative analysis using real-time reverse
transcriptase-polymerase chain reaction. Jpn J Cancer Res.
90:987–992. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zlobec I, Baker K, Terracciano LM and
Lugli A: RHAMM, p21 combined phenotype identifies microsatellite
instability-high colorectal cancers with a highly adverse
prognosis. Clin Cancer Res. 14:3798–3806. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang S, Chang MC, Zylka D, Turley S,
Harrison R and Turley EA: The hyaluronan receptor RHAMM regulates
extracellular-regulated kinase. J Biol Chem. 273:11342–11348. 1998.
View Article : Google Scholar : PubMed/NCBI
|
